Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer.
Saved in:
| Title: | Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer. |
|---|---|
| Authors: | Liu, Nan1 (AUTHOR), Wei, Wenwen1,2 (AUTHOR), Ren, Kexing2 (AUTHOR), Liang, Dandan1 (AUTHOR), Yang, Dong1 (AUTHOR), Zhang, Weishan1 (AUTHOR), Yang, Beibei2 (AUTHOR), Sun, Bin1 (AUTHOR), Zhao, Jincheng1 (AUTHOR), Cao, Dan3 (AUTHOR) caodan316@163.com, Zou, Liqun2 (AUTHOR) hxlcyxy@163.com, Zhao, Xudong1 (AUTHOR) zhaoxudong@wchscu.cn |
| Source: | Medcomm: Oncology. Mar2025, Vol. 4 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 184046243 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Liu%2C+Nan%22">Liu, Nan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wei%2C+Wenwen%22">Wei, Wenwen</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ren%2C+Kexing%22">Ren, Kexing</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Dandan%22">Liang, Dandan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Dong%22">Yang, Dong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Weishan%22">Zhang, Weishan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Beibei%22">Yang, Beibei</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Bin%22">Sun, Bin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Jincheng%22">Zhao, Jincheng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Dan%22">Cao, Dan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> caodan316@163.com</i><br /><searchLink fieldCode="AR" term="%22Zou%2C+Liqun%22">Zou, Liqun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> hxlcyxy@163.com</i><br /><searchLink fieldCode="AR" term="%22Zhao%2C+Xudong%22">Zhao, Xudong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> zhaoxudong@wchscu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Medcomm%3A+Oncology%22">Medcomm: Oncology</searchLink>. Mar2025, Vol. 4 Issue 1, p1-17. 17p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=184046243 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/mog2.70010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 1 Titles: – TitleFull: Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu, Nan – PersonEntity: Name: NameFull: Wei, Wenwen – PersonEntity: Name: NameFull: Ren, Kexing – PersonEntity: Name: NameFull: Liang, Dandan – PersonEntity: Name: NameFull: Yang, Dong – PersonEntity: Name: NameFull: Zhang, Weishan – PersonEntity: Name: NameFull: Yang, Beibei – PersonEntity: Name: NameFull: Sun, Bin – PersonEntity: Name: NameFull: Zhao, Jincheng – PersonEntity: Name: NameFull: Cao, Dan – PersonEntity: Name: NameFull: Zou, Liqun – PersonEntity: Name: NameFull: Zhao, Xudong IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 27696448 Numbering: – Type: volume Value: 4 – Type: issue Value: 1 Titles: – TitleFull: Medcomm: Oncology Type: main |
| ResultId | 1 |
